First Manhattan’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,600
| Closed | -$124K | – | 695 |
|
|
2024
Q2 | $124K | Hold |
10,600
| – | – | ﹤0.01% | 644 |
|
|
2024
Q1 | $223K | Hold |
10,600
| – | – | ﹤0.01% | 637 |
|
|
2023
Q4 | $190K | Sell |
10,600
-573,030
| -98% | -$10.3M | ﹤0.01% | 652 |
|
|
2023
Q3 | $9.61M | Buy |
583,630
+34,500
| +6% | +$568K | 0.04% | 147 |
|
|
2023
Q2 | $11M | Buy |
549,130
+101,400
| +23% | +$2.03M | 0.04% | 128 |
|
|
2023
Q1 | $8.47M | Buy |
447,730
+10,600
| +2% | +$200K | 0.03% | 157 |
|
|
2022
Q4 | $9.91M | Sell |
437,130
-268,600
| -38% | -$6.09M | 0.04% | 152 |
|
|
2022
Q3 | $18.7M | Hold |
705,730
| – | – | 0.08% | 101 |
|
|
2022
Q2 | $17.4M | Buy |
705,730
+9,365
| +1% | +$231K | 0.07% | 110 |
|
|
2022
Q1 | $23.1M | Buy |
696,365
+105,305
| +18% | +$3.5M | 0.08% | 105 |
|
|
2021
Q4 | $19.3M | Buy |
591,060
+22,792
| +4% | +$745K | 0.06% | 119 |
|
|
2021
Q3 | $23.8M | Buy |
568,268
+174,700
| +44% | +$7.32M | 0.09% | 100 |
|
|
2021
Q2 | $15.3M | Buy |
393,568
+60,178
| +18% | +$2.34M | 0.06% | 132 |
|
|
2021
Q1 | $11.4M | Sell |
333,390
-25,800
| -7% | -$880K | 0.05% | 147 |
|
|
2020
Q4 | $16.3M | Buy |
359,190
+259,847
| +262% | +$11.8M | 0.08% | 118 |
|
|
2020
Q3 | $2.73M | Buy |
99,343
+12,835
| +15% | +$353K | 0.01% | 268 |
|
|
2020
Q2 | $3.19M | Sell |
86,508
-1,700
| -2% | -$62.6K | 0.02% | 256 |
|
|
2020
Q1 | $2.86M | Buy |
+88,208
| New | +$2.86M | 0.02% | 264 |
|